Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Nucharee Yokdang"'
Autor:
Catalina Simion, Mingyi Chen, Dennis Chang, Jason Hatakeyama, Jessica H. Wald, William J. Murphy, Manojit Mosur Swamynathan, Joseph Tellez, Kermit L. Carraway, Colleen A Sweeney, Nucharee Yokdang
Publikováno v:
Oncogene, vol 35, iss 22
Oncogene
Oncogene
LRIG1 (leucine-rich repeat and immunoglobulin-like domain containing), a member of the LRIG family of transmembrane leucine-rich repeat-containing proteins, is a negative regulator of receptor tyrosine kinase signaling and a tumor suppressor. LRIG1 e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b61eb272705da658a63d06181ee1e92f
https://escholarship.org/uc/item/9v69m814
https://escholarship.org/uc/item/9v69m814
Autor:
Nucharee Yokdang, Iain L. O. Buxton
Publikováno v:
Cancers, Vol 3, Iss 3, Pp 2844-2857 (2011)
Cancers
Cancers
The notion that breast cancers can survive in an individual patient in a dormant state only to grow as metastatic disease in the future, is in our view incontrovertibly established. Convincing too is the evidence that surgery to remove the primary tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be4f994edc22541d0fd132f2604b881e
http://www.mdpi.com/2072-6694/3/3/2844/
http://www.mdpi.com/2072-6694/3/3/2844/
Autor:
J Norvell, M Valencik, Iain L. O. Buxton, H Tian, S H Barsky, Joseph Tellez, Nucharee Yokdang
Publikováno v:
British Journal of Cancer
Background: Human breast carcinoma cells secrete an adenosine 5′-diphosphate transphosphorylase (sNDPK) known to induce endothelial cell tubulogenesis in a P2Y receptor-dependent manner. We examined sNDPK secretion and its effects on human endothel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f50f086c2dbec044896c33bbf8463fa
https://doi.org/10.1038/bjc.2011.134
https://doi.org/10.1038/bjc.2011.134
Publikováno v:
British Journal of Cancer
P2Y purine nucleotide receptors (P2YRs) promote endothelial cell tubulogenesis through breast cancer cell-secreted nucleoside diphosphate kinase (NDPK). We tested the hypothesis that activated P2Y(1) receptors transactivate vascular endothelial growt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8284194b3ddf3a3721dbdb9579193648
http://europepmc.org/articles/PMC2694426
http://europepmc.org/articles/PMC2694426
Publikováno v:
Integrative Cancer Science and Therapeutics. 2
Nucleoside Diphosphate Kinase (NDPK), described as NM23 a metastasis suppressor, is found in the culture medium of cancer cells lines suggesting that the kinase may have an extracellular role. We propose that extracellular NM23 released from breast c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df63956f9ad93af4125393b254cd8870
https://doi.org/10.15761/icst.1000139
https://doi.org/10.15761/icst.1000139
Publikováno v:
The FASEB Journal. 27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f4feeb5dcb86d0daf9a69ec89845eaa
https://doi.org/10.1096/fasebj.27.1_supplement.1104.9
https://doi.org/10.1096/fasebj.27.1_supplement.1104.9
Autor:
Colleen A Sweeney, Mingyi Chen, Joseph Tellez, William J. Murphy, Jason Hatakeyama, Nucharee Yokdang, Jessica H. Wald, Manojit Mosur Swamynathan, Dennis Chang, Catalina Simion, Kermit L. Carraway
Publikováno v:
Cancer Research. 76:LB-021
LRIG1, a member of the LRIG family of transmembrane leucine rich repeat-containing proteins, is a negative regulator of receptor tyrosine kinase signaling and a tumor suppressor. LRIG1 expression is broadly decreased in human cancer and in breast can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de2c879d1725109cc8ac804a11440394
https://doi.org/10.1158/1538-7445.am2016-lb-021
https://doi.org/10.1158/1538-7445.am2016-lb-021
Publikováno v:
Cancer letters. 291(2)
Several advances have recently expanded models of tumor growth and promoted the concept of tumor homeostasis, the hypothesis that primary tumors exert an anti-proliferative effect on both themselves and subclinical secondary metastases. Recent trials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21f3ec62c0c9b31ad8cf816a09fd2511
https://pubmed.ncbi.nlm.nih.gov/19926395
https://pubmed.ncbi.nlm.nih.gov/19926395
Autor:
Colleen A Sweeney, Nucharee Yokdang
Publikováno v:
Cancer Research. 74:588-588
Leucine-rich repeats and immunoglobulin-like domains-1 (Lrig1) is known as a negative regulator of oncogenic receptor tyrosine kinases (ErbB, Met and Ret); and low Lrig1 expression correlates with poor patient prognosis in breast cancer. Lrig1 has be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14e7fa95fed357b06105a4cc8417551f
https://doi.org/10.1158/1538-7445.am2014-588
https://doi.org/10.1158/1538-7445.am2014-588
Autor:
Nucharee Yokdang
Publikováno v:
Cancer Research. 70:LB-366
Cancer cells promote angiogenesis early in tumorigenesis under mutagenic/hypoxic conditions that drive oncogene expression of pro-angiogenic proteins. Clinical data suggest that by the time women are diagnosed with breast cancer, micrometastases are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6d95b200d27a034f349ae704567c942
https://doi.org/10.1158/1538-7445.am10-lb-366
https://doi.org/10.1158/1538-7445.am10-lb-366